Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Roche”
- A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Australia, Belgium, Brazil, Chile +14 more
- A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia ARecruiting
Sponsor: Hoffmann-La Roche
Hemophilia A
United States
Sponsor: University Hospital, Bordeaux
Multiple Sclerosis, Primary Progressive
France
Sponsor: Hoffmann-La Roche
Urothelial Carcinoma · Bladder Cancer
United States, France, Greece, South Korea, Spain +2 more
Sponsor: Hoffmann-La Roche
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
United States, Australia, Israel, South Korea, Spain +2 more
Sponsor: Hoffmann-La Roche
Choroidal Neovascularization Secondary to Pathologic Myopia
Australia, China, France, Germany, Hong Kong +6 more
Sponsor: Hoffmann-La Roche
Neovascular Age-related Macular Degeneration (nAMD)
Argentina, Australia, Austria, Belgium, Brazil +11 more
Sponsor: Hoffmann-La Roche
Thyroid Eye Disease · TED
United States, Argentina, Australia, Austria, Germany +5 more
- A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular DegenerationActive Not Recruiting
Sponsor: Hoffmann-La Roche
Neovascular Age-related Macular Degeneration (nAMD)
United States, Australia, Canada, China, France +7 more
Sponsor: University of Southern California
Gastric Cancer · Esophageal Cancer
United States
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Australia, Belgium, Brazil +16 more
- ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung CarcinomaCompleted
Sponsor: ETOP IBCSG Partners Foundation
EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
Germany, Singapore, South Korea, Spain, Switzerland
- Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]Active Not Recruiting
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Australia, Belgium, China, France +16 more
- A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular CarcionmaActive Not Recruiting
Sponsor: Hoffmann-La Roche
Hepatocellular Carcinoma
China, Japan
Sponsor: Hoffmann-La Roche
Non-Hodgkin's Lymphoma
United States, Australia, Belgium, Canada, Czechia +8 more
- A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Australia, Austria, Belarus +32 more
- A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal CancerActive Not Recruiting
Sponsor: Hoffmann-La Roche
Rectal Neoplasms · Rectal Cancer
China
- A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial CancerActive Not Recruiting
Sponsor: Hoffmann-La Roche
Urothelial Cancer
United States, Australia, Brazil, China, Denmark +10 more
- Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion CarriersCompleted
Sponsor: Hoffmann-La Roche
Huntington Disease
United States, Argentina, Australia, Canada, Denmark +7 more
Sponsor: Hoffmann-La Roche
Paroxysmal Nocturnal Hemoglobinuria
United States, Belgium, Brazil, Czechia, Estonia +19 more
- A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab ProphylaxisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Severe Hemophilia A · Moderate Hemophilia A
United States, Brazil, Canada, Germany, Hungary +7 more
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Brazil, Canada +10 more
- Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular DegenerationActive Not Recruiting
Sponsor: Hoffmann-La Roche
Age-Related Macular Degeneration
United States, Israel
Sponsor: Hoffmann-La Roche
Dry Eye Disease
United States
- A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab StudyActive Not Recruiting
Sponsor: Hoffmann-La Roche
Cancer
United States, Australia, Belgium, Brazil, Bulgaria +19 more